Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
12.85
+0.12 (0.94%)
Nov 21, 2024, 4:00 PM EST - Market closed
Pliant Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 79.62 | 63.23 | 33.69 | 51.67 | 50.88 | 85.81 | Upgrade
|
| Short-Term Investments | 324.9 | 431.01 | 297.5 | 148.93 | 226.01 | 16.97 | Upgrade
|
| Cash & Short-Term Investments | 404.51 | 494.25 | 331.19 | 200.6 | 276.89 | 102.77 | Upgrade
|
| Cash Growth | -22.75% | 49.23% | 65.10% | -27.55% | 169.42% | 68.62% | Upgrade
|
| Accounts Receivable | - | - | 1.98 | 2 | 9.28 | 7.05 | Upgrade
|
| Other Receivables | 2.22 | 3 | 1.16 | 0.47 | 0.47 | 0.33 | Upgrade
|
| Receivables | 2.22 | 3 | 3.14 | 2.47 | 9.75 | 7.39 | Upgrade
|
| Prepaid Expenses | 1.85 | 4.53 | 4.85 | 5.4 | 3.36 | 1.74 | Upgrade
|
| Other Current Assets | 1.45 | 3.73 | 1.13 | 0.98 | 0.76 | - | Upgrade
|
| Total Current Assets | 410.03 | 505.5 | 340.31 | 209.44 | 290.75 | 111.9 | Upgrade
|
| Property, Plant & Equipment | 33.73 | 4.78 | 9.91 | 10.94 | 4.32 | 4.08 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 2.8 | Upgrade
|
| Other Long-Term Assets | 1.91 | 1.87 | 0.39 | 0.84 | 0.45 | 0.29 | Upgrade
|
| Total Assets | 445.67 | 512.15 | 350.61 | 221.22 | 295.53 | 119.06 | Upgrade
|
| Accounts Payable | 6.89 | 4.53 | 1.58 | 2.97 | 2.02 | 1.25 | Upgrade
|
| Accrued Expenses | 32.74 | 22.68 | 19.88 | 11.99 | 9.49 | 6.86 | Upgrade
|
| Current Portion of Leases | 0.32 | 1.32 | 2.46 | 1.87 | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.09 | 0.06 | Upgrade
|
| Total Current Liabilities | 39.95 | 28.52 | 23.91 | 16.83 | 11.6 | 8.17 | Upgrade
|
| Long-Term Debt | 30.14 | 10.05 | 9.93 | - | - | - | Upgrade
|
| Long-Term Leases | 29.75 | - | 3.43 | 5.33 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.87 | 0.91 | Upgrade
|
| Total Liabilities | 99.84 | 38.58 | 37.27 | 22.16 | 12.47 | 9.08 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,005 | 972.97 | 653.71 | 414.35 | 400.92 | - | Upgrade
|
| Retained Earnings | -660.32 | -499.75 | -338.41 | -215.09 | -117.83 | -76.3 | Upgrade
|
| Comprehensive Income & Other | 0.85 | 0.35 | -1.96 | -0.2 | -0.03 | -0 | Upgrade
|
| Total Common Equity | 345.82 | 473.58 | 313.34 | 199.06 | 283.06 | -76.3 | Upgrade
|
| Shareholders' Equity | 345.82 | 473.58 | 313.34 | 199.06 | 283.06 | 109.98 | Upgrade
|
| Total Liabilities & Equity | 445.67 | 512.15 | 350.61 | 221.22 | 295.53 | 119.06 | Upgrade
|
| Total Debt | 60.21 | 11.37 | 15.82 | 7.19 | - | - | Upgrade
|
| Net Cash (Debt) | 344.3 | 482.87 | 315.37 | 193.4 | 276.89 | 102.77 | Upgrade
|
| Net Cash Growth | -32.69% | 53.11% | 63.07% | -30.15% | 169.42% | 68.62% | Upgrade
|
| Net Cash Per Share | 5.71 | 8.22 | 7.51 | 5.40 | 12.97 | 63.31 | Upgrade
|
| Filing Date Shares Outstanding | 60.85 | 60.24 | 58.94 | 36.11 | 35.74 | 1.85 | Upgrade
|
| Total Common Shares Outstanding | 60.85 | 59.92 | 48.94 | 36.08 | 35.55 | 1.85 | Upgrade
|
| Working Capital | 370.08 | 476.98 | 316.4 | 192.61 | 279.16 | 103.73 | Upgrade
|
| Book Value Per Share | 5.68 | 7.90 | 6.40 | 5.52 | 7.96 | -41.33 | Upgrade
|
| Tangible Book Value | 345.82 | 473.58 | 313.34 | 199.06 | 283.06 | -76.3 | Upgrade
|
| Tangible Book Value Per Share | 5.68 | 7.90 | 6.40 | 5.52 | 7.96 | -41.33 | Upgrade
|
| Machinery | 13.77 | 10.53 | 9.61 | 7.97 | 6.56 | 5.6 | Upgrade
|
| Construction In Progress | 0.13 | 0.05 | 0.07 | 0.04 | 0.3 | 0.01 | Upgrade
|
| Leasehold Improvements | 2.12 | 1.66 | 1.65 | 1.62 | 0.95 | 0.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.